Stress in the brain: Implications for treatment of depression

Acta Neuropsychiatrica

Volumn 14, Issue 4, 2002, Pages 155-166

  De Kloet, Er ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Brain; Depression; Genes; Glucocorticoids; Hippocampus; Nuclear receptors; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; CELL NUCLEUS RECEPTOR; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GENE PRODUCT; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE PREDISPOSITION; DRUG TARGETING; FRONTAL CORTEX; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HORMONE ACTION; HORMONE INHIBITION; HUMAN; HYPERADRENOCORTICISM; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MATERNAL DEPRIVATION; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RISK FACTOR; SENESCENCE; SLEEP DISORDER; STRESS; TRANSCRIPTION REGULATION;

EID: 0036698167     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2002.140401.x     Document Type: Article

References (53)

1. De Kloet ER. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991;12:95-164.
2. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000;22:108-124.
3. Sapolsky R, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr Rev 2000;21:55-89.
4. Seckl JR. 11beta-hydroxysteroid dehydrogenase in the brain. a novel regulator of glucocorticoid action? Front Neuroendocrinol 1997;18:49-99.
5. Reul JMHM, De Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985;117:2502-2511.
6. De Kloet ER. Brain corticosteroid balance and homeostatic control. Front Neuroendocrinol 1991;12:95-164.
7. Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Med 2001;7:605-611.
8. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17:187-205.
9. Meijer OC, Steenbergen PJ, De Kloet ER. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 2000;141:2192-2198.
10. Wolkowitz OM. Prospective controlled studies of the behavioural and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 1994;19:233-255.
11. Joëls M, De Kloet ER. Mineralocorticoid and glucocorticoid receptors in the brain: implications for ion permeability and transmitter systems. Prog Neurobiol 1994;43:1-36.
12. Karten YJ, Nair SM, Van Essen I, Sibug R, Joëls M. Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurones. Proc Natl Acad Sci USA 1999;96:13456-13461.
13. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997;20:78-84.
14. Oitzl MS, Fluttert M, De Kloet ER. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticoisteroid receptors. Eur J Neurosci 1994;6:1072-1079.
15. Oitzl MS, De Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 1992;106:62-71.
16. Oitzl MS, Reichardt HM, Joëls M, De Kloet ER. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci USA 2001;98:12790-12795.
17. De Kloet ER, Oitzl MS, Joëls M. Stress and cognition. are corticosteroids good or bad guys? Trends Neurosci 1999;22:422-426.
18. Holsboer F, Laver CJ, Schreiber W, Krieg JC. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for depression. Neuroendocrinology 1995;62:340-347.
19. Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF. Increased numbers of corticotrophin releasing expressing neurones in the paraventricular nucleus of depressed patients. Neuroendocrinology 1994;60:436-444.
20. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Glucocorticoid feedback resistance. Trends Endocrinol Metabol 1997;8:26-33.
21. Meijer OC, De Lange ECM, Breimer DD, De Boer AG, Workel JO, De Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998;139:1789-1793.
22. Rubin RT, Phillips JJ, Sadow TF, McCracken JT. Adrenal gland volume in major depression. Arch Gen Psychiatry 1995;52:213-218.
23. Wolkowitz OM, Epel ES, Reus VI. Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psych 2001;2:115-144.
24. Lupien SJ, Lecours A, Lussier I, Schwartz G, Nair N, Meaney M. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994;14:2893-2903.
25. Lupien SJ, McEwen BS. The acute effects of corticosteroids on cognition: integration of animal and human studies. Brain Res Rev 1997;24:1-27.
26. Reul JM, Stec I, Soder M, Holsboer F. Chronic treatment of rats with the anti-depressant amitryptiline attenuates the activity of the hypothalamic-pituitary-adrenal activity. Endocrinology 1993;133:312-320.
27. Thakore JH, Dinan TG. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 1995;37:364-368.
28. Belanoff JK, Flores B, Kalezhan M, Sund B, Schatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 2001;21:516-521.
29. Holsboer F. Anti-depressant drug discovery in the postgenomic era. World J Biol Psych 2001;2:165-178.
30. De Kloet ER, Wallach G, Mcewen BS. Difference in binding of corticosterone and dexamethasone to rat brain and pituitary. Endocrinology 1975;96:598-611.
31. Ratka A, Sutanto W, Bloemers M, DE Kloet ER. On the role of mineralocorticoid (type 1) and glucocorticoid (type 2) receptors in neuroendocrine regulation. Neuroendocrinologyn 1989;50:117-123.
32. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996;52:597-617.
33. Grootendorst J, De Kloet ER, Vossen C, Dalm S, Oitzl MS. Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience. Neuroscience 2001;108:237-247.
34. Gesing A, Bilang-bleuel A, Droste SK, Linthorst AC, Holsboer F, Reul JM. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin releasing hormone. J Neurosci 2001;21:4822-4829.
35. Van Haarst AD, Oitzl MS, Workel JO, De Kloet ER. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 1996;137:4935-4943.
36. Oitzl MS, Van Haarst AD, Sutanto W, De Kloet ER. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 1995;20:655-677.
37. Rots NY, Cools AR, Oitzl MS, De Jong J, Sutanto W, De Kloet ER. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness. Endocrinology 1996;137:1678-1686.
38. Benus RF, Bohus B, Koolhaas JM, Van Oortmerssen GA. Behavioural differences between artificially selected aggressive and non-aggressive mice: response to apomorphine. Behav Brain Res 1991;43:203-208.
39. Veenema AH, Meijer OC, De Kloet ER, Koolhaas JM. Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Horm Behav, in press.
40. Levine S, Dent G, De Kloet ER. Stress-hyporesponsive period. In: Fink G, ed. Encyclopedia of stress, vol. 3. New York: Academic Press, 2000, 518-526.
41. Hofer M. On the relationship between attachment and separation processes in infancy. In: Plutnik R, Emtion B, eds. Early development. New York: Academic Press, 1993, 199-219.
42. Van Oers HJJ, De Kloet ER, Whelan T, Levine S. Maternal deprivation effect on the infants neural stress markers is reversed by tactile stimulation and feeding but not by suppressing corticosterone. J Neurosci 1998;18:10171-10179.
43. Rots NY, De Jong J, Workel JO, Levine S, Cools AR, De Kloet ER. Neonatal maternally deprived rats have as adults elevated basal pituitary-adrenal activity and enhanced susceptibility to apomorphine. J Neuroendocrinol 1996;8:501-506.
44. Meaney MJ, Aitken DH, Van Berkel C, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988;239:766-768.
45. Oitzl MS, Workel JO, Fluttert M, Frösch F, De Kloet ER. Maternal deprivation affects behaviour from youth to senescence: amplification of individual differences in spatial learning and memory in senescent brown Norway rats. Eur J Neuroscience 2000;34:372-378.
46. Workel JO, Oitzl MS, Fluttert M, Lesscher H, Karssen A, De Kloet ER. Differential and age-dependent effects of maternal deprivation on the hypothalamic-pituitary-adrenal axis of brown norway rats from youth to senescence. J Neuroendocrinol 2001;13:1-13.
47. Rinne TH, De Kloet ER, Goekoop J, De Rijk R, Van Den Brink W. Persistent effect of severe childhood abuse on the hypothalamus-pituitary-adrenal axis of adult female borderline patients. Biol Psychiatry in press.
48. Van Praag HM, Van Os J, Leonard BE, De Kloet ER. Stress and Depression, in press.
49. Datson NA, Van Der Perk J, De Kloet ER, Vreugdenhil E. Expression profile of 30,000 genes in rat hippocampus using SAGE. Hippocampus 2001;11:430-444.
50. Datson NA, Van Der Perk J, De Kloet ER, Vreugdenhil E. Identification of corticosteroid responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neuroscience 2001;14:1-17.
51. Karssen AM, Meijer OC, Van Der Sandt ICJ, Lucassen PJ, De Lange ECM, De Boer AG, De Kloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001;142:2686-2694.
52. Joëls M, De Kloet ER. Effects of glucocorticoids and norepinephrine in the excitability in the hippocampus. Science 1989;245:1502-1505.
53. Joëls M, Hesen W, De Kloet ER. Mineralcorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA 1 neurons. J Neuroscience 1991;11:2285-2294.